Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 8:01 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1513–1536 of 6,754 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: CHANGE Study Clear all

Conditions: Focal Epilepsy, Temporal Lobe Epilepsy, Medically Refractory Epilepsy, Memory Disorders, Epilepsy Comorbidities, Epilepsy Intractable, Epilepsy Surgery, Epilepsy, Temporal Lobe, Memory Deficits, Memory Disorder, Spatial, Memory Dysfunction, Spatial Perception
Interventions: Virtual Tour Recognition Memory Task, Intracranial EEG Recording with Research Electrodes (Aim III only), MRI Neuroimaging and Neuropsychological Assessment (Aim I); Behavioral · Device · Diagnostic Test
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years to 55 Years
Enrollment: 620 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2030
U.S. locations: 2
States / cities: Sacramento, California • Atlanta, Georgia

Conditions: Stroke
Interventions: Cognitive-Oriented Strategy Augmented Rehabilitation (COSTAR), Task Specific Training (TST); Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Healthy
Interventions: PF-06650833, Placebo; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Stress (Psychology), Resilience, Psychological, Anxiety, Depressive Symptoms, Well-being, Sleep Quality
Interventions: Wearable ring with continuous biometric monitoring, AI health coaching application, Osteopathic manipulative treatment (OMT); Device · Behavioral · Other
Lead sponsor: Touro University, California; Other
Eligibility: 18 Years and older
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Vallejo, California

Conditions: Insufficient Physical Activity
Interventions: 5 Behavioral Change Techniques; Behavioral
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Dysphagia, Aspiration
Interventions: 3-Screenings Protocol, FEES, Tracheal Ultrasound; Diagnostic Test
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 855 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 5
States / cities: Stanford, California • Aurora, Colorado • New Haven, Connecticut + 1 more

Conditions: Behavior, Child, Food Selection
Interventions: Basic School Lunchroom Nudges; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 10 Years to 15 Years
Enrollment: 3,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 6
States / cities: Columbus, Ohio

Conditions: Functional Constipation (FC), Chronic Idiopathic Constipation (CIC)
Interventions: Placebo for Linaclotide, Linaclotide; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 2 Years to 5 Years
Enrollment: 123 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 38
States / cities: Foley, Alabama • Phoenix, Arizona • Hot Springs, Arkansas + 33 more

Conditions: Multiple Sclerosis
Interventions: Not listed
Lead sponsor: Simnad, Virginia, M.D.; Individual
Eligibility: 21 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Kirkland, Washington

Conditions: Healthy
Interventions: Ritalin, Placebo; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 70 Years to 80 Years
Enrollment: 97 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 4
States / cities: Long Beach, California • Hollywood, Florida • South Miami, Florida + 1 more

Conditions: Vasomotor Symptoms Associated With Menopause, Hot Flashes
Interventions: Elinzanetant (BAY3427080), Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 40 Years to 65 Years · Female only
Enrollment: 396 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 55
States / cities: Birmingham, Alabama • Mesa, Arizona • Scottsdale, Arizona + 47 more

Conditions: Solid Tumor, Hematological Malignancies
Interventions: Belinostat, Atazanavir; Drug
Lead sponsor: Acrotech Biopharma Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Santa Monica, California

Conditions: Blood Pressure Monitoring, Blood Pressure
Interventions: Chest Worn Blood Pressure Monitor; Device
Lead sponsor: Perin Health Devices; Industry
Eligibility: 22 Years to 90 Years
Enrollment: 196 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Louisville, Colorado

Conditions: Physical Inactivity
Interventions: Cognitive training, Exercise; Behavioral
Lead sponsor: University of Iowa; Other
Eligibility: 40 Years to 65 Years
Enrollment: 264 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Iowa City, Iowa • Boston, Massachusetts

Conditions: Prostate Cancer, Adenocarcinoma
Interventions: Hypofractionated, image-guided, intensity-modulated external beam radiation; Radiation
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years to 85 Years · Male only
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2026
U.S. locations: 7
States / cities: Commack, New York • Harrison, New York • New York, New York + 4 more

Conditions: Obesity
Interventions: Weight loss counseling, Portion-Controlled Foods; Behavioral · Dietary Supplement
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Ulcerative Colitis (UC)
Interventions: Mesalamine, Placebo; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 5 Years to 17 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 8
States / cities: Washington D.C., District of Columbia • Jacksonville, Florida • Atlanta, Georgia + 5 more

Conditions: Metastatic Colorectal Cancer (mCRC)
Interventions: FOLFIRI plus bevacizumab, mFOLFOX6 plus bevacizumab; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 9,978 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Somerville, Massachusetts

Conditions: Obesity
Interventions: VeSTAL; Device
Lead sponsor: Neurovalens Ltd.; Industry
Eligibility: 22 Years to 80 Years
Enrollment: 241 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 3
States / cities: La Jolla, California • Austin, Texas

Conditions: Muscular Atrophy, Spinal
Interventions: Risdiplam; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 3 Months to 24 Months
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 11
States / cities: Little Rock, Arkansas • Aurora, Colorado • Gainesville, Florida + 8 more

Conditions: Sepsis
Interventions: Vital Signs at 2 Hours, Confusion Assessment method for the ICU (CAM-ICU); Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 110 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Chronic Pain
Interventions: GetActive-Fitbit, Healthy Living for Pain; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 92 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 3
States / cities: Chicago, Illinois • Boston, Massachusetts • Durham, North Carolina

Conditions: Postural; Defect
Interventions: Education for Behavior Modification, Corrective Exercise Program; Behavioral
Lead sponsor: Liberty University; Other
Eligibility: 18 Years to 29 Years
Enrollment: 79 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Lynchburg, Virginia

Conditions: Congenital Adrenal Hyperplasia, 21-Hydroxylase Deficiency, Adrenogenital Syndrome
Interventions: Chronocort, Cortef; Drug
Lead sponsor: Neurocrine UK Limited; Industry
Eligibility: 16 Years to 60 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Bethesda, Maryland

Search by objective public record fields.

Spatial Scene Recognition Memory in Epilepsy Surgery

Cognitive Oriented Strategy Training Augmented Rehabilitation (COSTAR) Treatment Approach for Stroke

Study to Evaluate Safety and Tolerability of Single Ascending Doses of Multiple Formulations of PF-06650833 in Healthy Subjects Under Fasted and Fed Conditions

High-Tech, High-Touch

A BCT Intervention for Physical Activity Among Individuals on Statins

Aspiration in Acute Respiratory Failure Survivors 2

Nudging for Behavior Change in School Cafeterias

A Study to Assess Adverse Events and Change in Symptoms With Linaclotide Versus Placebo in Pediatric Subjects, Ages 2 to 5 Years, With Functional Constipation

A Pilot Study Assessing the Impact of Gilenya Therapy on Bone Density Change in Relapsing Forms of Multiple Sclerosis

A Study To Evaluate The Difference In iPad-Based Cognitive Video Game (Akili Interactive's Project: EVO) Performance In Amyloid-Positive Versus Amyloid-Negative Healthy Elderly Volunteers

A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause

Extension Study for Patients Who Had Not Met Criteria for Discontinuation in Previous Sponsored Belinostat Trials

Noninvasive Blood Pressure Validation Study

Cognitive Control to Boost Physical Activity Adherence

Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer

A Randomized Trial Comparing Two Doses of Portion-Controlled Foods Within a Primary Care Weight Loss Program

A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis

Emulation of the MAVERICC Trial Using Specialty Oncology Electronic Health Records Databases

Vestibular Stimulation to Trigger Adipose Loss (VeSTAL) Clinical Trial

A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy

Sepsis Pre-Alert Monitoring Intervention: Study to Investigate Targeted Enhanced Monitoring for Sepsis

The Thrive Study: Improving Multimodal Physical Function in Adults With Heterogenous Chronic Pain

Effects of Postural Education or Corrective Exercise on Forward Head Posture

Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia